PDCD1 and melanoma: In addition, it has been shown that enhancing fatty acid (FA) catabolism in conditions of low O2 and glucose improves TILs’ ability to kill cancer cells and that the use of peroxisome proliferator-activated receptor (PPAR)-alpha agonist enhances the therapeutic effect of PD-1 blockade in melanoma [98].